428 related articles for article (PubMed ID: 8209383)
1. Lactate dehydrogenase activity and isozyme patterns in tissues and bronchoalveolar lavage fluid from rats treated with monocrotaline pyrrole.
Schultze AE; Gunaga KP; Wagner JG; Hoorn CM; Moorehead WR; Roth RA
Toxicol Appl Pharmacol; 1994 Jun; 126(2):301-10. PubMed ID: 8209383
[TBL] [Abstract][Full Text] [Related]
2. Fibrinolytic activity in blood and lungs of rats treated with monocrotaline pyrrole.
Schultze AE; Roth RA
Toxicol Appl Pharmacol; 1993 Jul; 121(1):129-37. PubMed ID: 7687795
[TBL] [Abstract][Full Text] [Related]
3. Early indications of monocrotaline pyrrole-induced lung injury in rats.
Schultze AE; Wagner JG; White SM; Roth RA
Toxicol Appl Pharmacol; 1991 Jun; 109(1):41-50. PubMed ID: 2038748
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of procoagulant activity in the peripheral blood of rats treated with monocrotaline pyrrole.
Schultze AE; Wagner JG; Roth RA
Toxicol Appl Pharmacol; 1991 Jul; 109(3):421-31. PubMed ID: 1830177
[TBL] [Abstract][Full Text] [Related]
5. Procoagulant and fibrinolytic properties of bovine endothelial cells treated with monocrotaline pyrrole.
Schultze AE; Roth RA
Toxicol Appl Pharmacol; 1993 Sep; 122(1):7-15. PubMed ID: 8378934
[TBL] [Abstract][Full Text] [Related]
6. Effects of monocrotaline pyrrole on cultured rat pulmonary endothelium.
Hoorn CM; Wagner JG; Roth RA
Toxicol Appl Pharmacol; 1993 Jun; 120(2):281-7. PubMed ID: 8511798
[TBL] [Abstract][Full Text] [Related]
7. Cellular fibronectin and von Willebrand factor concentrations in plasma of rats treated with monocrotaline pyrrole.
Schultze AE; Emeis JJ; Roth RA
Biochem Pharmacol; 1996 Jan; 51(2):187-91. PubMed ID: 8615888
[TBL] [Abstract][Full Text] [Related]
8. COR pulmonale is caused by monocrotaline and dehydromonocrotaline, but not by glutathione or cysteine conjugates of dihydropyrrolizine.
Pan LC; Wilson DW; Lamé MW; Jones AD; Segall HJ
Toxicol Appl Pharmacol; 1993 Jan; 118(1):87-97. PubMed ID: 8430429
[TBL] [Abstract][Full Text] [Related]
9. Lack of effect of deferoxamine, dimethyl sulfoxide, and catalase on monocrotaline pyrrole pulmonary injury.
Bruner LH; Johnson K; Carpenter LJ; Roth RA
J Toxicol Environ Health; 1987; 21(1-2):205-17. PubMed ID: 3573071
[TBL] [Abstract][Full Text] [Related]
10. Monocrotaline pyrrole induces apoptosis in pulmonary artery endothelial cells.
Thomas HC; Lamé MW; Dunston SK; Segall HJ; Wilson DW
Toxicol Appl Pharmacol; 1998 Aug; 151(2):236-44. PubMed ID: 9707500
[TBL] [Abstract][Full Text] [Related]
11. Comparative cytotoxicity of monocrotaline and its metabolites in cultured pulmonary artery endothelial cells.
Taylor DW; Wilson DW; Lamé MW; Dunston SD; Jones AD; Segall HJ
Toxicol Appl Pharmacol; 1997 Mar; 143(1):196-204. PubMed ID: 9073608
[TBL] [Abstract][Full Text] [Related]
12. Monocrotaline pyrrole-induced cardiopulmonary toxicity is not altered by metergoline or ketanserin.
Ganey PE; Sprugel KH; Hadley KB; Roth RA
J Pharmacol Exp Ther; 1986 Apr; 237(1):226-31. PubMed ID: 2937908
[TBL] [Abstract][Full Text] [Related]
13. Hypertrophy and prolonged DNA synthesis in smooth muscle cells characterize pulmonary arterial wall thickening after monocrotaline pyrrole administration to rats.
Lappin PB; Roth RA
Toxicol Pathol; 1997; 25(4):372-80. PubMed ID: 9280120
[TBL] [Abstract][Full Text] [Related]
14. The response of pulmonary vascular endothelial cells to monocrotaline pyrrole: cell proliferation and DNA synthesis in vitro and in vivo.
Lappin PB; Ross KL; King LE; Fraker PJ; Roth RA
Toxicol Appl Pharmacol; 1998 May; 150(1):37-48. PubMed ID: 9630451
[TBL] [Abstract][Full Text] [Related]
15. Development of morphologic, hemodynamic, and biochemical changes in lungs of rats given monocrotaline pyrrole.
Reindel JF; Ganey PE; Wagner JG; Slocombe RF; Roth RA
Toxicol Appl Pharmacol; 1990 Nov; 106(2):179-200. PubMed ID: 2256110
[TBL] [Abstract][Full Text] [Related]
16. NTP Toxicology and Carcinogenesis Studies of Talc (CAS No. 14807-96-6)(Non-Asbestiform) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 421():1-287. PubMed ID: 12616290
[TBL] [Abstract][Full Text] [Related]
17. Effects of altered platelet number on pulmonary hypertension and platelet sequestration in monocrotaline pyrrole-treated rats.
White SM; Wagner JG; Roth RA
Toxicol Appl Pharmacol; 1989 Jun; 99(2):302-13. PubMed ID: 2734793
[TBL] [Abstract][Full Text] [Related]
18. The spontaneously hypertensive rat as a model of human cardiovascular disease: evidence of exacerbated cardiopulmonary injury and oxidative stress from inhaled emission particulate matter.
Kodavanti UP; Schladweiler MC; Ledbetter AD; Watkinson WP; Campen MJ; Winsett DW; Richards JR; Crissman KM; Hatch GE; Costa DL
Toxicol Appl Pharmacol; 2000 May; 164(3):250-63. PubMed ID: 10799335
[TBL] [Abstract][Full Text] [Related]
19. Injury to the isolated, perfused lung by exposure in vitro to monocrotaline pyrrole.
Hilliker KS; Roth RA
Exp Lung Res; 1985; 8(4):201-12. PubMed ID: 4043006
[TBL] [Abstract][Full Text] [Related]
20. Effects of thrombocytopenia on monocrotaline pyrrole-induced pulmonary hypertension.
Hilliker KS; Bell TG; Lorimer D; Roth RA
Am J Physiol; 1984 Jun; 246(6 Pt 2):H747-53. PubMed ID: 6742140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
